Ionis Pharmaceuticals (United States)
In research, Ionis Pharmaceuticals (United States) stands highest in Life Sciences (#3,101 of 7,800 worldwide) and Biochemistry, Genetics and Molecular Biology (#2,363 of 3,579 worldwide), 2022–2025. Relative to its size it is most specialised in Molecular Biology — Molecular Biology is 10.4× its share of world research.
- World rank, 2022–2025
- #7,497 of 28,054 · #3,530 all time
- Rank in United States
- #993 of 4,192
- Research works
- 1.7k ▼ 3% vs 2013–17
- Citations
- 99k 59.8 per fractional work
- Top-10% rate
- 23.2% record average 16.5%
- Open access
- 35% world 28%
What is Ionis Pharmaceuticals (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #3,101 of 7,800 | 22.5% | 79 | #1501 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,363 of 3,579 | 22.5% | 61 | #926 |
Each strip is that field’s whole ranked pool, with the notch where Ionis Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Ionis Pharmaceuticals (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 10.4× the share of its output that it takes of world research.
- Molecular BiologySubfield · 45.4 works10×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.9×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.9×
- Immunology and Microbiology 7.1×
- Veterinary 3.0×
- Neuroscience 2.7×
- Medicine 1.9×
- Chemistry 1.8×
- Nursing 1.2×
- Economics, Econometrics and Finance 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Agricultural and Biological Sciences 0.2×
- Materials Science 0.2×
- Environmental Science 0.1×
- Engineering 0.1×
- Mathematics 0.1×
- Health Professions 0.1×
- Computer Science 0.1×
- Psychology 0.1×
- Physics and Astronomy 0.0×
- Decision Sciences 0.0×
Who are the top researchers at Ionis Pharmaceuticals (United States)?
Ranked on the composite score, C. Frank Bennett, Brett P. Monia and Stanley T. Crooke lead among researchers whose main affiliation is Ionis Pharmaceuticals (United States).
- 1 C. Frank Bennett United States · #14,619 worldwide 809 citations · 45 works
- 2 Brett P. Monia United States · #22,879 worldwide 509 citations · 48 works
- 3 Stanley T. Crooke United States · #74,437 worldwide 708 citations · 97 works
- 4 Richard S. Geary United States · #94,883 worldwide 259 citations · 33 works
- 5 Frank Rigo United States · #126,055 worldwide 210 citations · 39 works
- 6 Steven G. Hughes United States · #129,085 worldwide 241 citations · 23 works
- 7 David J. Ecker United States · #131,887 worldwide 216 citations · 32 works
- 8 Muthiah Manoharan United States · #150,527 worldwide 271 citations · 51 works
- 9 Eric E. Swayze United States · #154,738 worldwide 199 citations · 36 works
- 10 Qingqing Yang United States · #161,605 worldwide 253 citations · 21 works
Which keywords describe research at Ionis Pharmaceuticals (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Antisense Oligonucleotides, Metabolic Syndrome, Genomic Stability, DNA Structure, G-Quadruplexes, Atherosclerosis and Cancer.
- Cancer Progression
- Neuroinflammation
- Apoptosis
- Genetics
- Neurological Disorders
- Alternative Splicing
- ANGPTL3
- Hereditary Angioedema
- siRNA Delivery
- RNA Interference
- Gene Silencing
- Innate Immunity
- Insulin Resistance
- Mitochondrial Dysfunction
- Cardiovascular Disease
- Gene Therapy
- G-Quadruplexes
- Genomic Stability
- Cancer
- Antisense Oligonucleotides
- Inflammation
- Metabolic Syndrome
- Oxidative Stress
- DNA Structure
- Atherosclerosis
- Thrombosis
- Nanoparticles
- Neurodegeneration
- Biosensors
- Obesity
- DNA nanotechnology
- Self-Assembly
- Adipose Tissue
- Kinin Receptor Family
- Lipoprotein Lipase
- Genetic Mutations
- RNA-Binding Proteins
- Gene Regulation
- Chaperones
- Protein Aggregation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation15▲ 4.9×37 topics
- Antisense Oligonucleotides10▲ 160×2 topics
- Metabolic Syndrome9▲ 8.0×9 topics
- Cancer9▲ 4.5×31 topics
- Oxidative Stress8▲ 3.5×19 topics
- Genomic Stability8▲ 151×2 topics
- DNA Structure8▲ 266×1 topic
- G-Quadruplexes8▲ 266×1 topic
- Atherosclerosis7▲ 18×6 topics
- Gene Therapy6▲ 22×4 topics
- Thrombosis6▲ 15×5 topics
- Cardiovascular Disease6▲ 3.7×15 topics
- Nanoparticles6▲ 3.0×7 topics
- Mitochondrial Dysfunction5▲ 13×8 topics
- Neurodegeneration5▲ 13×9 topics
- Insulin Resistance5▲ 7.8×6 topics
- Biosensors5▲ 6.6×2 topics
- Innate Immunity5▲ 11×9 topics
- Obesity5▲ 4.5×9 topics
- Gene Silencing5▲ 34×2 topics
- DNA nanotechnology5▲ 27×1 topic
- RNA Interference5▲ 38×1 topic
- Self-Assembly5▲ 10×1 topic
- siRNA Delivery5▲ 55×1 topic
- Adipose Tissue4▲ 58×2 topics
- Hereditary Angioedema4▲ 149×1 topic
- Kinin Receptor Family4▲ 149×1 topic
- ANGPTL34▲ 198×1 topic
- Lipoprotein Lipase4▲ 198×1 topic
- Alternative Splicing4▲ 50×1 topic
- Genetic Mutations4▲ 6.0×13 topics
- Neurological Disorders4▲ 4.5×8 topics
- RNA-Binding Proteins4▲ 50×1 topic
- Genetics4▲ 3.6×8 topics
- Gene Regulation3▲ 23×4 topics
- Apoptosis3▲ 6.5×10 topics
- Chaperones3▲ 32×2 topics
- Neuroinflammation3▲ 6.7×3 topics
- Protein Aggregation3▲ 36×3 topics
- Cancer Progression3▲ 9.9×5 topics
Which research topics does Ionis Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: DNA and Nucleic Acid Chemistry, Advanced biosensing and bioanalysis techniques, RNA Interference and Gene Delivery and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 DNA and Nucleic Acid Chemistry Molecular Biology 8 works
- 2 Advanced biosensing and bioanalysis techniques Molecular Biology 5 works
- 3 RNA Interference and Gene Delivery Molecular Biology 5 works
- 4 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 4 works
- 5 Lipid metabolism and disorders Cardiology and Cardiovascular Medicine 4 works
- 6 RNA Research and Splicing Molecular Biology 4 works
- 7 RNA and protein synthesis mechanisms Molecular Biology 2 works
- 8 Alzheimer's disease research and treatments Physiology 2 works
- 9 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 2 works
- 10 RNA regulation and disease Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ionis Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 3% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Carlsbad
- Jones Institute
- Gemological Institute of America
- Viasat (United States)
- Flometrics (United States)
- Neuroscience Education Institute
- Lineage Cell Therapeutics (United States)
- Structural Analytics (United States)
- Advanced Brain Monitoring (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.